The Impact of COVID-19 is included in Swine Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Swine Vaccine Trends and Forecast
The future of the global swine vaccine market looks promising with opportunities in the classical swine fever, porcine parvovirus, and swine influenza markets. The global swine vaccine market is expected to reach an estimated $2.6 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing preference for antibiotic-free disease preventive approaches, supportive government initiatives for managing swine diseases, and rising awareness about diseases like influenza A among livestock farmers.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Swine Vaccine by Segment
The study includes a forecast for the global swine vaccine by product, disease type, and region.
Swine Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Recombinant
• Inactivated
Swine Vaccine Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:
• Classical Swine Fever
• Porcine Parvovirus
• Swine Influenza
• Others
Swine Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Swine Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies swine vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the swine vaccine companies profiled in this report include-
• Merck Animal Health
• Ceva
• Zoetis
• Boehringer Ingelheim
• Elanco
• Indian Immunologicals
• BiogénesisBagó
• Phibro Animal Health
• KM Biologics
• HIPRA
Swine Vaccine Market Insights
Lucintel forecasts that inactivated will remain the larger segment due to its widespread availability, affordability, and low risk of revert reaction of destroyed viruses.
Within this market, porcine parvovirus will remain the largest segment over the forecast period.
APAC is expected to witness highest growth over the forecast period due to the presence of leading swine production hubs and existence of large meat-consuming population in the region.
Features of the Global Swine Vaccine Market
Market Size Estimates: Swine vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Swine vaccine market size by product, disease type, and region in terms of value ($B).
Regional Analysis: Swine vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, disease types, and regions for the swine vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the swine vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the swine vaccine market size?
Answer: The global swine vaccine market is expected to reach an estimated $2.6 billion by 2030.
Q.2 What is the growth forecast for swine vaccine market?
Answer: The global swine vaccine market is expected to grow with a CAGR of 6.9% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the swine vaccine market?
Answer: The major drivers for this market are growing preference for antibiotic-free disease preventive approaches, supportive government initiatives for managing swine diseases, and rising awareness about diseases like influenza A among livestock farmers.
Q4. What are the major segments for swine vaccine market?
Answer: The future of the swine vaccine market looks promising with opportunities in the classical swine fever, porcine parvovirus, and swine influenza markets.
Q5. Who are the key swine vaccine market companies?
Answer: Some of the key swine vaccine companies are as follows:
• Merck Animal Health
• Ceva
• Zoetis
• Boehringer Ingelheim
• Elanco
• Indian Immunologicals
• BiogénesisBagó
• Phibro Animal Health
• KM Biologics
• HIPRA
Q6. Which swine vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that inactivated will remain the larger segment due to its widespread availability, affordability, and low risk of revert reaction of destroyed viruses.
Q7. In swine vaccine market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to the presence of leading swine production hubs and existence of large meat-consuming population in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the swine vaccine market by product (recombinant and inactivated), disease type (classical swine fever, porcine parvovirus, swine influenza, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Swine Vaccine Market, Swine Vaccine Market Size, Swine Vaccine Market Growth, Swine Vaccine Market Analysis, Swine Vaccine Market Report, Swine Vaccine Market Share, Swine Vaccine Market Trends, Swine Vaccine Market Forecast, Swine Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Swine Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Swine Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Swine Vaccine Market by Product
3.3.1: Recombinant
3.3.2: Inactivated
3.4: Global Swine Vaccine Market by Disease Type
3.4.1: Classical Swine Fever
3.4.2: Porcine Parvovirus
3.4.3: Swine Influenza
3.4.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Swine Vaccine Market by Region
4.2: North American Swine Vaccine Market
4.2.2: North American Swine Vaccine Market by Disease Type: Classical Swine Fever, Porcine Parvovirus, Swine Influenza, and Others
4.3: European Swine Vaccine Market
4.3.1: European Swine Vaccine Market by Product: Recombinant and Inactivated
4.3.2: European Swine Vaccine Market by Disease Type: Classical Swine Fever, Porcine Parvovirus, Swine Influenza, and Others
4.4: APAC Swine Vaccine Market
4.4.1: APAC Swine Vaccine Market by Product: Recombinant and Inactivated
4.4.2: APAC Swine Vaccine Market by Disease Type: Classical Swine Fever, Porcine Parvovirus, Swine Influenza, and Others
4.5: ROW Swine Vaccine Market
4.5.1: ROW Swine Vaccine Market by Product: Recombinant and Inactivated
4.5.2: ROW Swine Vaccine Market by Disease Type: Classical Swine Fever, Porcine Parvovirus, Swine Influenza, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Swine Vaccine Market by Product
6.1.2: Growth Opportunities for the Global Swine Vaccine Market by Disease Type
6.1.3: Growth Opportunities for the Global Swine Vaccine Market by Region
6.2: Emerging Trends in the Global Swine Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Swine Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Swine Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Merck Animal Health
7.2: Ceva
7.3: Zoetis
7.4: Boehringer Ingelheim
7.5: Elanco
7.6: Indian Immunologicals
7.7: BiogénesisBagó
7.8: Phibro Animal Health
7.9: KM Biologics
7.10: HIPRA
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Swine Vaccine Market Report.